Identification of colon tumor marker NKD1 via integrated bioinformatics analysis and experimental validation.

The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu Province, China. Clinical Oncology Laboratory, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou, Changzhou, China. Department of Oncology, Wujin Hospital Affiliated with Jiangsu University, Jiangsu Province, China. Department of Oncology, The Wujin Clinical College of Xuzhou Medical University, Jiangsu Province, China.

Cancer medicine. 2021;(20):7383-7394
Full text from:

Other resources

Abstract

BACKGROUND Colorectal cancer is an important death-related disease in the worldwide. However, specific colon cancer tumor markers currently used for diagnosis and treatment are few. The purpose of this study is to screen the potential colon cancer markers by bioinformatics and verify the results with experiments. METHODS Gene expression data were downloaded from two different databases: TCGA database and GEO datasets, which were then analyzed by two different methods (difference analysis and WGCNA method). Venn and PPI analysis obtained the potential core genes, which were then performed the GO enrichment and KEGG pathway analysis. Expressions levels of NKD1 in colon carcinoma tissues were further confirmed by immunohistochemical staining and western blot assays. Moreover, the function was measured by MTT, clone formation, and tumor transplantation experiments. Importantly, co-immunoprecipitation, immunofluorescence, and protein stability assays were further performed to explore the underlying mechanism of NKD1 promoting cell proliferation. RESULTS Nine potential core genes highly expressed in colon cancer samples were screened out by bioinformatics analysis. NKD1, one of the hub genes, highly expressed in the colon carcinoma tissues could enhance the proliferation of colon cancer cells. Mechanism research demonstrated that NKD1 was essential for the combination between Wnt signalosome (DVL) and β-catenin, and that NKD1 knockout remarkably decreased the β-catenin expression. Immunofluorescence assays further implied that NKD1 knockout significantly inhibited β-catenin nuclear accumulation. Importantly, the stability of β-catenin proteins was maintained by NKD1 in the colon cancer cells. CONCLUSION We believe that NKD1 well expressed in the colorectal carcinoma tissues can enhance the proliferation of colon cancer cells. Furthermore, the functions that NKD1 may have in colon cancer cells should be different from that NKD1 has played in the zebrafish. Thus, NKD1 could be a specific colorectal cancer marker.